| Shree Ganesh Biotech India Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 539470 |
NSE Symbol : - |
P/E(TTM) : 33.33 |
|
ISIN Demat : INE051N01026 |
Div & Yield% : - |
EPS(TTM) : 0.03 |
|
Book Value(₹) : 1.59 |
Market Cap(₹Cr) : 39.86 |
Face Value(₹) : 1.00 |
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 1.98 | 3.56 | 3.78 | 4.12 | 4.12 | 8.25 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1.98 | 3.56 | 3.78 | 4.12 | 4.12 | 8.25 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.30 | 0.37 | 1.06 | 0.00 | 0.00 | 0.00 |
| Total Income | 2.29 | 3.92 | 4.84 | 4.12 | 4.12 | 8.25 |
| Total Expenditure | 1.96 | 3.69 | 4.30 | 4.04 | 4.04 | 8.10 |
| PBIDT | 0.32 | 0.24 | 0.54 | 0.09 | 0.08 | 0.15 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | 0.32 | 0.24 | 0.54 | 0.09 | 0.08 | 0.15 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 0.32 | 0.24 | 0.54 | 0.09 | 0.08 | 0.15 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.32 | 0.24 | 0.54 | 0.09 | 0.08 | 0.15 |
| EPS (Unit Curr.) | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| EPS (Adj) (Unit Curr.) | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Calculated EPS (Unit Curr.) | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Calculated EPS (Adj) (Unit Curr.) | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.03 | 0.02 | 0.05 | 0.01 | 0.01 | 0.01 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.03 | 0.02 | 0.05 | 0.01 | 0.01 | 0.01 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 39.86 | 39.86 | 39.86 | 39.86 | 39.86 | 39.86 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 16.16 | 6.74 | 14.29 | 2.18 | 1.94 | 1.82 |
| PBDTM(%) | 16.16 | 6.74 | 14.29 | 2.18 | 1.94 | 1.82 |
| PATM(%) | 16.16 | 6.74 | 14.29 | 2.18 | 1.94 | 1.82 |